Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial

Characterization of Pulmonary Hypertension in Heart Failure Using the Diastolic Pressure Gradient

(2015) Neal A. Chatterjee et al.   JACC-Heart Failure

Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1)

(2014) Diana Bonderman et al.   CHEST

Right Ventricular Function in Heart Failure With Preserved Ejection Fraction

(2014) Selma F. Mohammed et al.   CIRCULATION

Heart Failure With Preserved Ejection Fraction

(2014) Kavita Sharma et al.   CIRCULATION RESEARCH

Right heart dysfunction in heart failure with preserved ejection fraction

(2014) Vojtech Melenovsky et al.   EUROPEAN HEART JOURNAL

The pathophysiology of heart failure with preserved ejection fraction

(2014) Barry A. Borlaug   Nature Reviews Cardiology

Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction

(2013) Margaret M. Redfield et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pulmonary Hypertension Due to Left Heart Diseases

(2013) Jean-Luc Vachiéry et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

B-Type Natriuretic Peptide and Prognosis in Heart Failure Patients With Preserved and Reduced Ejection Fraction

(2013) Dirk J. van Veldhuisen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Letter by Forfia and Borlaug Regarding Article, “Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study”

(2012) Paul R. Forfia et al.   CIRCULATION

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

(2012) et al.   EUROPEAN JOURNAL OF HEART FAILURE

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

(2012) Scott D Solomon et al.   LANCET

Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction

(2011) Marco Guazzi et al.   CIRCULATION

Epidemiology and clinical course of heart failure with preserved ejection fraction

(2010) Carolyn S.P. Lam et al.   EUROPEAN JOURNAL OF HEART FAILURE

Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure

(2009) Dirk Westermann et al.   BASIC RESEARCH IN CARDIOLOGY

Caveat medicus! Pulmonary hypertension in the elderly: a word of caution

(2009) Barry A. Boilson et al.   EUROPEAN JOURNAL OF HEART FAILURE

Guidelines for the diagnosis and treatment of pulmonary hypertension

(2009) et al.   EUROPEAN RESPIRATORY JOURNAL

Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor-Neprilysin Inhibitor (ARNi)

(2009) Jessie Gu et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Sildenafil Stops Progressive Chamber, Cellular, and Molecular Remodeling and Improves Calcium Handling and Function in Hearts With Pre-Existing Advanced Hypertrophy Caused by Pressure Overload

(2009) Takahiro Nagayama et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction

(2009) Carolyn S.P. Lam et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY